The CDC Advisory Committee on Immunization Practices (ACIP) recently recommended Pfizer’s tick-borne encephalitis (TBE) vaccine, TicoVac, to prevent TBE in individuals one year and older.
ACIP...
Moderna recently expanded its mRNA pipeline with three new development programs, including an HSV mRNA vaccine, a varicella-zoster virus (VZV) vaccine, and a checkpoint cancer vaccine.
First, Moderna...
Eli Lilly and Company recently launched an education campaign to educate, support, connect, and empower people diagnosed with early breast cancer (EBC) with a high risk of recurrence.
The campaign,...
Gilead recently announced one-year results from an ongoing Phase 2/3 CAPELLA trial evaluating its HIV-1 capsid inhibitor, lenacapavir, in individuals with multi-drug resistant HIV.
The trial...
Moderna and ROVI recently entered into a long-term collaboration to increase capacities for the compounding, aseptic filling, inspection, and manufacturing of mRNA vaccines and medicines over the next...
Merck recently announced that Keytruda, combined with chemotherapy and followed by Keytruda as monotherapy, prolonged event-free survival compared to chemotherapy followed by placebo in patients with...
AstraZeneca recently announced that its combination chemotherapy treatment improved radiographic progression-free survival (rPFS) compared to standard-of-care for metastatic castration-resistant...
Bristol Myers Squibb recently granted $7.965 million to 24 US non-profit organizations to improve access to care for medically underserved patients across oncology, cardiology, immunology, and...
Biogen and Xbrane Biopharma recently agreed to develop, manufacture, and commercialize a preclinical monoclonal antibody and proposed biosimilar, Xcimzane, referencing Cimzia.
Cimzia is a drug...
ViiV Healthcare, GSK, and Shionogi recently entered a $1.25-billion settlement over the global patent infringement litigation with Gilead concerning its HIV drug combined with three HIV integrase...
Abbott recently announced the world's first implant of a dual-chamber leadless pacemaker system as part of its Aveir DR i2i pivotal clinical trial.
The prospective investigational study will...
Biogen recently exercised its option to participate in the development and commercialization of Genentech’s bispecific antibody, mosunetuzumab.
Mosunetuzumab is a CD20xCD3 T-cell engaging...
Pfizer and Valneva recently announced further positive results from the Phase 2 clinical trial evaluating their Lyme disease vaccine candidate, VLA15.
The trial, VLA15-221, enrolled 294 healthy adult...
FDA recently approved Takeda Pharmaceutical’sPharmaceutical’s Vonvendi for routine prophylaxis to reduce the frequency of bleeding episodes in patients with severe Type 3 von Willebrand...
Personalized immunotherapy from an individual’s tumor-fighting immune cells could potentially treat metastatic breast cancer, according to a study from the National Cancer Institute’s...
FDA recently approved an update to the prescribing information for Kite’s Yescarta to include prophylactic corticosteroids across all approved indications.
The agency first approved Yescarta in...
Modern and IAVI recently dosed the first two patients in a clinical trial of experimental HIV vaccine antigens at the George Washington University (GWU) School of Medicine and Health Sciences.
The...
Most pregnant and postpartum women with opioid use disorder (OUD) in US jails do not receive medication that is standard of care, a JAMA Network Open study found.
The cross-sectional study surveyed...
FDA recently accepted for review Regeneron’s biologics license application for its PD-1 inhibitor, Libtayo, in combination with chemotherapy to treat advanced non-small cell lung cancer...
